The manuscript for "Open Systems Pharmacology community - an open access, open source, open science approach to modeling and simulation in pharmaceutical sciences" was accepted for publication in CPT: Pharmacometrics & Systems Pharmacology on September 23, 2019.
The Grand Challenges 2018 Annual Meeting (Oct 15-18, 2018) featured a panel on PBPK modeling and simulation in advancing drug development in global health. Dr. Edginton was invited by the Bill & Melinda Gates Foundation to participate along with:
Congratulations to Paul Malik for receiving a three year CIHR Doctoral Scholarship ($105,000 over three years). The tenure of the award is 2018-2021.
Andrea Edginton PhD, Michael Neely, MD (University of Southern California) and Joerg Lippert PhD (Bayer, Germany) receive a US FDA grant ($900,000 US 2018-2021) on PBPK and Population Modeling Seamlessly Linked to Clinical Trial Simulation in an Open-Source Software Platform.
Dr. Andrea Edginton, Dr. Shinya Ito (SickKids, Toronto) and Dr. Julie Autmizguine (St. Justine Hospital, Montreal) received a 4-year $680,000 CIHR Project grant awarded in Spring 2018. The project abstract is as follows:
"Predicting escitalopram exposure to breastfeeding infants: integrating analytical and in silico techniques", has been accepted for publication in Clinical Pharmacokinetics.
This manuscript presents a workflow for integrating breastmilk concentrations, feeding schedules and infant exposure through physiologically-based pharmacokinetic modelling for the purpose of hazard assessment. The work is the collaboration of SickKids in Toronto and The Pharmacokinetics Research Group (Edginton) at University of Waterloo.
Dr. Alfonso Iorio (McMaster) (NPA), Dr. Andrea Edginton (PA), Dr. Man Chiu Poon (U Calgary) (PA) received a 3-yr project grant (Fall 2017 competition) entitled:
Personalized Medicine for Canadians with Hemophilia: a pragmatic evaluation of Web-Accessible Population Pharmacokinetics Service-Hemophilia (WAPPS-hemo) tailored dosing
This research will evaluate the effectiveness, safety and economics of the WAPPS-Hemo platform (www.wapps-hemo.org) in personalizing hemophilia treatment through pharmacokinetic modeling at 5 Canadian hemophilia centres.
Dr. Edginton has been invited to the Bill & Melinda Gates Medical Research Institute event -- 2018 PD Challenge Workshop: Collaborating to Improve Translational Medicine in Global Health being held April 26-27, 2018 at the Boston Marriott Copley Place.
The 2018 American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting is in Orlando, FL on March 21-24. The following abstracts will be presented:
Malik PRV, Edginton AN. Pediatric physiology in relation to the disposition of monoclonal antibodies.
Dr. Edginton will moderate a two hour workshop on pharmacokinetics in hemophilia at the 9th Annual Bayer Hemophilia Conference. The conference runs from November 2-4, 2017 in Amsterdam, NL.